Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9W3V

Structure of Csm6 from Actinomyces procaprae in complex with cyclic hexa-adenylate

9W3V の概要
エントリーDOI10.2210/pdb9w3v/pdb
EMDBエントリー65610
分子名称Csm6, RNA (5'-R(P*AP*AP*AP*AP*AP*A)-3') (2 entities in total)
機能のキーワードcsm6, ancillary nuclease, allosteric activation, cyclic oligoadenylate, type iii crispr, immune system/rna, immune system-rna complex
由来する生物種Actinomyces procaprae
詳細
タンパク質・核酸の鎖数8
化学式量合計349526.20
構造登録者
Lin, Z.,Gao, H.,Shi, R.,Yang, M.,Liu, Y. (登録日: 2025-07-30, 公開日: 2026-03-04, 最終更新日: 2026-04-22)
主引用文献Shi, R.,Yang, M.,Liu, Y.,Gao, H.,Lin, Z.
Mechanistic basis for selective Csm6-2 activation by cyclic penta-adenylate in a type III CRISPR-Cas system.
Embo J., 2026
Cited by
PubMed Abstract: Type III CRISPR systems generate cyclic oligoadenylate (cOA, 3 to 6 AMPs) messengers upon detecting viral RNA, activating downstream effectors to defend against viral infection. Although cOA-activated effectors have been extensively characterized, the effectors specific to cA5-one of the most abundant cOA species produced during phage infection-have remained unexplored. Here, we report that the CRISPR ribonuclease Csm6 (Csm6-2) from Actinomyces procaprae selectively employs cA5 as its activator. Csm6-2 utilizes its HEPN domain, rather than the CARF domain, to mediate self-limiting cleavage of cOA activators. Cryo-EM structural analyses reveal that Csm6-2 functions as a homotetramer, and disruption of tetramer formation significantly reduces its ribonuclease activity. Although cA6 and cA5 bind Csm6-2 with comparable affinity, only cA5 induces CARF domain closure, stabilizes the tetramer, and remodels the active site in the HEPN domain. In contrast, the sixth AMP of cA6 imposes significant steric hindrance on CARF domain movement, preventing its closure and subsequent allosteric activation. These findings expand our understanding of the cOA signaling diversity and specific cOA recognition mechanisms in type III CRISPR immunity.
PubMed: 41917262
DOI: 10.1038/s44318-026-00767-3
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (2.53 Å)
構造検証レポート
Validation report summary of 9w3v
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon